Table 5.
Mean comparision of depression score between male and female patients in citalopram and escitalopram group (during baseline, week 4, week 8, and week 12).
| Escitalopram Group: | |||
|---|---|---|---|
| Treatment Duration | Escitalopram group Depression score in male Mean ± SD |
Escitalopram group Depression score in female Mean ± SD |
Mean Difference (P-value) |
| Baseline | 10.4 ± 5.54 | 12.5 ± 4.87 | 2.17 (0.190) |
| Week 4 | 24.7 ± 5.7 | 28.1 ± 7.58 | 3.14 (0.110) |
| Week 8 | 15.8 ± 4.40 | 17.59 ± 4.96 | 0.653 (0.375) |
| Week 12 |
10.4 ± 3.48 |
10.4 ± 3.69 |
0.028 (0.980) |
| CITALOPRAM GROUP | |||
| Treatment Duration |
Citalopram group Depression score in male Mean ± SD |
Citalopram group Depression score in females Mean ± SD |
Mean Difference (P-value) |
| Baseline | 9.11 ± 4.84 | 10.19 ± 3.15 | 1.07 (0.409) |
| Week 4 | 25.5 ± 4.03 | 26.1 ± 5.91 | 0.642 (0.699) |
| Week 8 | 14.2 ± 3.20 | 16.8 ± 4.40 | 0.70 (0.320) |
| Week 12 | 13.66 ± 2.80 | 14.6 ± 3.18 | 0.952 (0.332) |